Stockwinners Market Radar for July 26, 2023 - Earnings, Upgrades downgrades, option trades, Best Stock Advisory Service

22:02 EDT Samsung sees earnings improving in System LSI segment - The company states: "Weak smartphone demand caused by the economic slowdown and inflation delayed the recovery of semiconductor demand, and customers continued with their inventory adjustments. As a result, the business delivered lower-than-expected results. Despite the difficult environment, the business won a design award for automotive SoCs with a domestic OEM for their premium 2025 model, and it continued to work to expand SoC applications and strengthen business competitiveness via active discussions with European customers regarding mid- to long-term cooperation. Earnings should improve thanks to recovering demand-driven by peak IT seasonality-for parts such as SoCs and DDIs, and as customers wind down inventory adjustments."

19:24 EDT SLB exec sells $1.01M in common stock - In a regulatory filing, SLB disclosed that its New Energy President Gavin Rennick sold 18K shares of common stock on July 24th in a total transaction size of $1.01M.

18:55 EDT Analog Devices invests over $1B in semiconductor facility expansion in Oregon - Analog Devices celebrated its more than $1B investment to expand its semiconductor wafer fab in Beaverton, Oregon. The Beaverton site, built in 1978, is ADI's largest wafer fabrication facility by volume and serves customers in critical industries, such as industrial, automotive, communications, consumer, and healthcare. The facility investment expands cleanroom space to about 118,000 sq-ft and nearly doubles internal manufacturing of products running on the 180-nanometer technology node and above. It is also expected to create hundreds of new, long-term employment opportunities, a significant increase to ADI's current roughly 950 employees in Oregon. More than 10% of the total investment is for new, state-of-the-art fab tools intended to increase overall efficiency and utilize chemistries that are more environmentally friendly. Despite nearly doubling production output, the facility is targeting to reduce absolute greenhouse gas emissions by approximately 75% and water usage per production unit by approximately 50%. "By expanding ADI's Beaverton facility, we are increasing our production capacity in critical industries, boosting domestic manufacturing in line with the vision of the CHIPS Act, and enhancing the global resiliency of ADI's hybrid manufacturing model," said Vincent Roche, ADI's CEO and Chair. "While our investment in Beaverton will facilitate these goals, they will be achieved through the incredible dedication and talent of ADI's existing workforce and further tapping into Oregon's strong talent pool."

18:24 EDT Chipotle CEO: We've seen a bit of a pullback in delivery - In an interview on CNBC's Mad Money, Brian Niccol said he believes more people will shift to order ahead and to Chipotlanes. Chicken Al Pastor has driven a lot of transactions, he noted.

18:15 EDT HSBC raises prime rate to 8.50% - HSBC Bank USA, N.A., and its affiliates announced today that they have raised their prime and reference rate to 8.50% from 8.25%, effective tomorrow.

17:48 EDT Simply Good Foods director sells $11.33M in common stock - In a regulatory filing, Simply Good Foods disclosed that its director Brian Ratzan sold 300K shares of common stock on July 24th in a total transaction size of $11.33M.

17:32 EDT U.S. Bancorp increases prime lending rate to 8.5% from 8.25% - U.S. Bancorp announced it has increased its prime lending rate to 8.5% from 8.25%, effective tomorrow, July 27, 2023, at all U.S. Bank locations. The prime lending rate replaces the reference rate formerly used by MUFG Union Bank, National Association.

17:25 EDT Impinj falls 16% to $65.85 after Q2 results, below-consensus guidance

17:24 EDT National Vision falls 9% at $22.62 after announcing end of pact with Walmart

17:21 EDT Lockheed Martin awarded $489.46M Navy contract modification - Lockheed Martin was awarded a $489.46M modification to a cost-plus-fixed-fee, firm-fixed-price order against a previously issued basic ordering agreement. This modification adds scope to procure various material mod kits, special test/tooling equipment, as well as provides product engineering, and installation in support of retrofit and modification engineering change proposal efforts on F-35 aircraft to correct aircraft deficiencies and upgrade F-35 aircraft with Technology Refresh Three for the Air Force, Marine Corps, Navy, Foreign Military Sales, or FMS, customers and non-U.S. Department of Defense, or DOD, participants. Work will be performed in Fort Worth, Texas, and is expected to be completed in March 2028. The Naval Air Systems Command is the contracting activity.

17:20 EDT Northern Trust raises prime rate to 8.50% from 8.25%, effective July 27

17:13 EDT Meta Platforms says seeing more people come back to Threads daily than expected - Says Facebook now has more than 3B monthly active users. Says groundbreaking AI products in the pipeline. Says quite optimistic on Threads trajectory. Says seeing more people come back daily than expected. Says as good as start as can ask for. Says leaner organization can build higher quality products faster and Threads is an example. Says will still hire in key areas. Says working through figuring out right amount of AI capital expenditures. Says riding AI in the near term and the metaverse in the long term. Comments taken from Q2 earnings conference call.

17:12 EDT Mattel says 'Barbie' film a 'milestone moment' for the company - Mattel (MAT) says "Barbie" opened to "incredible success." Says success of first weekend made it "more than a movie," but rather a "phenomenon." Says company could not be prouder of achievements of Greta Gerwig, Warner Bros. (WBD), and the cast. Says film a 'milestone moment' for the company. Says "Barbie" success speaks to potential and value of IP in film space. Comments taken from Q2 earnings conference call.

17:04 EDT Webster Financial raises prime rate to 8.50% from 8.25%, effective July 27 - Webster Financial Corporation announced that it has raised its prime lending rate to 8.50% from 8.25%, effective July 27.

17:03 EDT Oceaneering sees FY23 SSR operating income improving significantly - "For SSR, we expect operating income to improve significantly on a high-teens percentage increase in revenue, and EBITDA margin to average in the low 30% range. ROV fleet utilization is expected to average in the mid- to high-60% range for the year," the company said. "For Manufactured Products, we forecast a significant increase in revenue and operating income, as compared to 2022. Although we expect lower operating income margin during the second half of the year as a result of changes in project mix, we continue to expect operating margin for the full year to improve over 2022, averaging in the mid-single digit percentage range for the year. Bidding activity in our energy and AMR businesses remains robust and we continue to expect our full-year book-to-bill ratio to be in the range of 1.2 to 1.4. For OPG, we expect slightly higher revenue, significantly higher operating income results and improved operating income margin to the low- to mid-teens percentage range, driven by more efficient vessel utilization and increased international activity. Robust offshore activity is expected to continue through the fourth quarter. For IMDS, we forecast relatively flat operating income results on modestly higher revenue, with operating income margin remaining in the mid-single digit percentage range for the year. For ADTech, we expect higher operating income results on increased revenue with an annual operating income margin in the low-teens percentage range."

17:01 EDT Community Trust raises dividend 4.5% to 46c - On July 25 the Board of Directors of Community Trust Bancorp increased its quarterly cash dividend to 46c per share beginning with the October 1 payment to shareholders of record on September 15. This represents an increase of 4.5% in the quarterly cash dividend.

16:56 EDT Citizens Financial raises prime rate to 8.50% from 8.25%, effective July 27

16:49 EDT Krystal expands R&D pipeline to oncology, announces FDA acceptance of KB707 IND - Krystal Biotech announced that it has expanded its R&D pipeline to oncology and that the FDA has accepted its investigational new drug, or IND, application of its lead oncology drug candidate KB707 for the treatment of locally advanced or metastatic solid tumor malignancies. The company will host an investor conference call and webcast, Thursday, July 27 to discuss the KB707 program.

16:46 EDT PNC Bank raises prime lending rate to 8.5% - PNC Bank announced an increase in its prime lending rate. The new rate of 8.50% is effective tomorrow, July 27, 2023.

16:41 EDT Delek Logistics raises dividend 1% to $1.035 - Delek Logistics Partners declared its quarterly cash distribution for the Q2 of $1.035 per common limited partner unit, or $4.14 per common limited partner unit on an annualized basis. This distribution represents a 1.0% increase from the distribution for the Q1 of $1.025 per common limited partner unit and a 5.1% increase over Delek Logistics' distribution for the Q2 of 98.5c per common limited partner unit. Q2 cash distribution is payable on August 14 to unitholders of record on August 7.

16:41 EDT Enovix establishes research and design center in India, Enovix India - Enovix announced it has established Enovix Research and Development Services India Private Limited or Enovix India, in Hyderabad. The Enovix India team will develop advanced models to predict battery performance and support next-gen battery manufacturing and design. "I'm pleased to announce we officially established our expansion into India with a dedicated R&D center in Hyderabad," said Dr. Raj Talluri, President and CEO of Enovix. "The region is a strategic location for us due to its deep pool of technical talent in fields that are of utmost importance to our long-term success, as well as its business-friendly environment. This significant milestone marks another chapter in our journey to scale." "I am excited to lead the talented Enovix team and establish a strong presence in India," said Dr. Saravanan. "In my experience, having a dedicated team focused on battery modeling, optimization, Machine Learning and data analysis will give us an even greater advantage in achieving new breakthroughs in battery innovation." Enovix India has established a board of directors including Dr. Saravanan. The team is hiring for multiple roles in the region and intends to grow significantly over the next 18 months.

16:40 EDT TriNet raises share repurchase plan by $1B - TriNet stock repurchase program increased by $1B to bring the total available for repurchase to $1.4B as of July 26, 2023 to be deployed subject to market conditions.

16:39 EDT CACI awarded $209M fleet readiness contract from U.S. Navy - CACI International announced that it was awarded a five-year, single-award $209 million mission expertise prime contract by the U.S. Fleet Forces Command (USFFC) to provide global logistics and technical training support to Naval Forces Logistics (NFL). "Our history with the Navy dates back to CACI's first contract award in 1963 with the Navy's Ships Parts Control Center, which has evolved into this work today," said CACI President and Chief Executive Officer John Mengucci. "This latest award represents another vote of confidence in CACI's performance and innovation. Our long-standing dedication to the Navy's mission will ensure that its global logistics and training programs evolve and modernize, while supporting Sailors to stay ahead of rapidly advancing adversaries and threats." Under the expanded contract, CACI will continue to provide advanced mission software and modern capabilities needed to ensure readiness and decision advantage across all domains. CACI's rapid capability upgrades and technology offer the Navy expert global logistics support and technical proficiency, including analysis and problem-solving, installation and setup of various computer systems and software, database and system administration, financial management, on-site assistance, training, implementation, and program management.

16:38 EDT Quaker Houghton raises quarterly dividend 5% to 45.5c per share - The Board of Directors of Quaker Houghton declared a 45.5c per share quarterly cash dividend, an increase of approximately 5% over the prior dividend. The quarterly dividend is payable on October 31 to shareholders of record at the close of business on October 17.

16:38 EDT QuantumScape backs FY23 capex view of $100M-$150M

16:37 EDT Antelope Enterprise Holdings receives non-compliance letter from Nasdaq - Antelope Enterprise Holdings, the operator of KylinCloud, announced that on July 25 it received a deficiency letter from the Listing Qualifications Department of the Nasdaq Stock Market. The deficiency letter advised that for the last 30 consecutive business days the bid price for the Company's Class A ordinary shares had closed below the minimum $1.00 per share requirement for continued inclusion on the Nasdaq Capital Market pursuant to Nasdaq Listing Rule 5550. The deficiency letter does not result in the immediate delisting of the Company's common stock from the Nasdaq Capital Market.

16:37 EDT Regions Bank raises prime lending rate to 8.5% - Regions Bank announced it is increasing the Regions prime lending rate to 8.50% from 8.25%, effective Thursday, July 27, 2023.

16:36 EDT Midwest Holding's shareholders approve merger agreement - Midwest Holding announced that at a special meeting of stockholders held earlier today, its shareholders approved the previously announced merger agreement whereby an affiliate of international investment firm Antarctica Capital will acquire Midwest for $27.00 per share in cash. According to final results from the Special Meeting, approximately 69% of the outstanding shares voted in favor of the transaction, representing more than 99% of the votes cast. The transaction is expected to close in the second half of 2023, subject to certain customary closing conditions, including the receipt of remaining insurance regulatory approvals.

16:34 EDT VSE Corp. raises FY223 revenue growth view to 25%-30% from 10%-15% - Consensus $866.7M. The company states: "Aviation segment full year 2023 revenue guidance is increasing from 10% to 15% to 25% to 30% growth, as compared to the prior year, to reflect contributions from the recent Desser Aerospace acquisition and improved performance within distribution and MRO sales channels. Aviation segment expects Adjusted EBITDA margin to be at the higher end of its previously provided guidance range of 13% to 15%. Fleet segment full year 2023 revenue guidance is increasing from 12 to 20% to 20 to 25% growth, as compared to the prior year, to reflect strong growth in USPS sales and commercial customer market share gains. Fleet segment is maintaining its Adjusted EBITDA margin guidance range of 11 to 13%. The Company maintains its outlook for positive free cash flow in the second half of 2023."

16:33 EDT Employers Holdings board authorizes $50M share repurchase program - The Board of Directors has authorized a new stock repurchase program to allow for repurchases of up to $50M of its common stock from July 31, 2023 through December 31, 2024. The new program replaces a similar program that was scheduled to expire on December 31, 2023, but whose remaining repurchase authorization had been exhausted.

16:29 EDT Bank of Montreal raises U.S. prime lending rate to 8.50% from 8.25% - Effective July 27.

16:24 EDT Carvana drops 3% to $42.57 after Morgan Stanley downgrade

16:22 EDT Associated Banc-Corp raises from 8.25% to 8.5% - Associated Banc-Corp, the holding company for Associated Bank, announced it has increased the bank's prime rate from 8.25% to 8.5%, effective July 26.

16:20 EDT Allison Transmission awarded U.S. Army contract, terms not stated - Allison Transmission "will provide the Allison eGen ForceTM electric hybrid system for American Rheinmetall Vehicles' Team Lynx prototype. Team Lynx, led by ARV, was recently selected for Phases 3 and 4 in the U.S. Army's Optionally Manned Fighting Vehicle competition, now named the XM30 Combat Vehicle program. The XM30 Combat Vehicle program (formerly OMFV) is the priority ground modernization five-phased program for the U.S. Army that will replace nearly 3,000 Bradley Infantry Fighting Vehicles. Only two competitors were awarded contracts for Phases 3 and 4 Detailed Design and Prototype Build and Test. Team Lynx will now complete the designs that began in the Phase 2 Concept Design phase and build prototypes for U.S. Army evaluation beginning in 2026 with final selection and Low-Rate Initial Production to begin in late 2027."

16:15 EDT National Vision to record impairment charges - The company states: "The Company expects EBITDA contribution from Walmart and its affiliate businesses in fiscal 2023 to be lower than in fiscal 2022. In connection with the termination of these agreements, the Company expects to record noncash goodwill and intangible asset impairment charges of approximately $60 million and $10 million, respectively, in the third quarter of fiscal 2023."

16:14 EDT Ameriprise announces additional $3.5B share repurchase authorization - The Board of Directors of Ameriprise Financial has authorized an additional $3.5 billion for the repurchase of shares of its common stock through September 30, 2025. As of July 25, 2023, the company had approximately $0.5 billion available from its January 2022 authorization, which is available through March 31, 2024. The company intends to fund share repurchases through existing excess capital, future free cash flow generation and other customary financing methods. The share repurchase program does not require the purchase of any minimum number of shares, and depending on market conditions and other factors, these purchases may be commenced or suspended at any time without prior notice. Acquisitions under the share repurchase program may be made in the open market, through privately negotiated transactions or block trades or other means. In addition, the Board of Directors has declared a quarterly cash dividend of $1.35 per common share payable on August 18, 2023 to shareholders of record at the close of business on August 7, 2023.

16:13 EDT Comfort Systems USA raises quarterly dividend to 22.5c per share - Comfort Systems USA announced that its board of directors declared a quarterly dividend of $0.225 per share, which is a $0.025 increase from the Company's most recent dividend, on Comfort Systems USA, Inc. common stock. The dividend is payable on August 28, 2023 to stockholders of record at the close of business on August 17, 2023.

16:12 EDT Chipotle sees FY23 comparable restaurant sales growth mid to high-single digits - For 2023, management is anticipating the following: Full year comparable restaurant sales growth in the mid to high-single digit range; 255 to 285 new restaurant openings (including 10 to 15 relocations to add a Chipotlane), which assumes utility, construction, permit and material supply delays do not worsen; An estimated underlying effective full year tax rate between 25% and 27% before discrete items.

16:11 EDT Chipotle sees Q3 comparable restaurant sales growth low to mid-single digits

16:10 EDT Covenant Logistics says in the midst of very difficult operating environment - Parker concluded, "We are pleased with our second quarter results and are excited about the opportunity Lew Thompson & Son gives us to improve upon them through the combination of a full quarter impact of their operations, as well as anticipated near-term opportunities for growth. Our results were achieved in the midst of what we consider the trough of a very difficult operating environment that spanned across the entire quarter. We are optimistic about the future but remain cautious about the pace of recovery in the freight market. Our team is intensely focused on capital allocation and cost control across our entire enterprise. We believe our more resilient operating model, together with the steps we are taking to reduce costs and inefficiencies, will continue to mitigate a portion of our historical volatility throughout economic and freight market cycles. Overall, I am pleased with our current position, which features a moderately-leveraged balance sheet, ample liquidity and a reduction of approximately 14% of the diluted weighted average shares outstanding compared to a year ago. We will remain focused on growing our market share, continuing to improve our operations, and becoming a stronger, more profitable, and more predictable business with the opportunity for significant and sustained value creation."

16:10 EDT Meta Platforms up 6% in after-hours following Q2 report - Meta shares are up $17.53, or 6%, to $316.10 in after-hours trading.

16:09 EDT Netstreit raises quarterly dividend by 2.5% to 20.5c per share - Netstreit declared a quarterly cash dividend of 20.5 per share for Q3. On an annualized basis, the dividend of 82c per share of common stock represents an increase of 2c per share over the previous annualized dividend. The dividend will be paid on September 15, to shareholders of record on September 1.

16:08 EDT Enovix sees Q3 production 36,000 units - The company said, "In the third quarter of 2023, we forecast production of approximately 36,000 units based on continued operational improvements. For full-year 2023, we continue to forecast spending $120 million of cash operationally but are lowering our CapEx forecast from $120 million to $70 million. This is due primarily to CapEx payments for our first Gen2 Autoline that we previously forecast to spend directly that are being covered by the local funding in Malaysia."

16:07 EDT Fluor awarded EPC contract by Mitsubishi Chemical - Fluor announced that it was awarded an engineering, procurement and construction, or EPC, contract by Mitsubishi Chemical Group for its SoarnoL ethylene vinyl alcohol copolymer facility in Saltend Chemicals Park, Hull, United Kingdom. Fluor booked its undisclosed portion of the contract in the second quarter of 2023. SoarnoL is a high gas-barrier resin used to produce packaging materials that help extend the flavor and quality of foods, resulting in reduced food waste. In addition, multilayer films containing SoarnoL are certified as highly recyclable in combination with Mitsubishi.

16:06 EDT eBay reports Q2 GMV $18.2B, down 2% on as-reported basis

16:00 EDT KeyCorp raises prime lending rate to 8.50% from 8.25%, effective July 27

15:45 EDT Maxlinear trading resumes

15:20 EDT Santander Bank raises prime rate to 8.50% - Santander Bank, N.A., a wholly-owned subsidiary of Madrid-based Banco Santander, S.A., announced it has raised its prime rate from 8.25% to 8.50%, effective July 26.

15:07 EDT BMW, GM, others create JV to accelerate EV transition in North America - BMW Group (BMWYY), General Motors (GM), Honda (HMC), Hyundai (HYMLF), Kia, Mercedes-Benz Group (DDAIF), Stellantis NV (STLA) are creating a joint venture to accelerate the transition to electric vehicles in North America, by making EV charging more convenient, accessible and reliable. The joint venture will include the development of a new, high-powered charging network with at least 30,000 chargers to make zero-emission driving even more attractive for millions of customers. With the generational investments in public charging being implemented on the Federal and State level, the joint venture will leverage public and private funds to accelerate the installation of high-powered charging for customers. The new charging stations will be accessible to all battery-powered electric vehicles from any automaker using Combined Charging System (CCS) or North American Charging Standard and are expected to meet or exceed the spirit and requirements of the U.S. National Electric Vehicle Infrastructure program. The joint venture aims to become the leading network of reliable high-powered charging stations in North America. The joint venture is expected to be established this year, subject to customary closing conditions and regulatory approvals. The first stations are expected to open in the United States in the summer of 2024 and in Canada at a later stage. Each site will be equipped with multiple high-powered DC chargers, making long-distance journeys easier for customers. In line with the sustainability strategies of all seven automakers, the joint venture intends to power the charging network solely by renewable energy.

15:01 EDT Maxlinear trading halted, news pending

14:56 EDT Mercedes-Benz raises FY23 EBIT to same level as last year - Previous view slightly below. Sees FY23 Vans adjusted Return on sales 13%-15%, previous view 11%-13%.

14:05 EDT Fifth Third Bank raises prime lending rate to 8.5% - Fifth Third Bank announced it will increase its prime lending rate to 8.50%, effective immediately. The rate was last changed on May 3, 2023, when Fifth Third increased its prime lending rate from 8.00% to 8.25%.

13:05 EDT Twilio, AWS expand partnership for AI capabilities - Amazon Web Services (AMZN) and Twilio (TWLO) announced an extension of their longstanding strategic work together that will place powerful artificial intelligence capabilities at the fingertips of Twilio customers. This news follows the recent announcement of Twilio CustomerAI. One priority area where AWS and Twilio are doubling down is the implementation of predictive AI technology. Bringing together Amazon SageMaker technology and Twilio Segment's Customer Data Platform, the upcoming features will help businesses better understand their customers and empower them to provide deeper value to them via more relevant, timely, and personalized experiences. In particular, marketers and data scientists will soon have out-of-the-box access to new machine learning powered tools that can intelligently anticipate future customer actions and help inform product or marketing strategy.

12:19 EDT Amazon Web Services announces AI-powered service AWS HealthScribe - Amazon Web Services announced AWS HealthScribe, a new HIPAA-eligible service that empowers healthcare software providers to build clinical applications that use speech recognition and generative AI to save clinicians time by generating clinical documentation. With AWS HealthScribe, healthcare software providers can use a single API to automatically create robust transcripts, extract key details, and create summaries from doctor-patient discussions that can then be entered into an electronic health record system. Powered by Amazon Bedrock, AWS HealthScribe makes it faster and easier for healthcare software providers to integrate generative AI capabilities into their application starting with two popular specialties, without needing to manage the underlying machine learning infrastructure or train their own healthcare-specific large language models. AWS HealthScribe enables responsible deployment of AI systems by citing the source of every line of generated text from within the original conversation transcript, making it easier for physicians to review clinical notes before entering them into the EHR. Built with security and privacy in mind, AWS HealthScribe gives customers control over where their data is stored, encrypts data in transit and at rest, and does not use inputs or outputs generated through the service to train its models.

12:00 EDT Silgan Holdings falls -13.6% - Silgan Holdings is down -13.6%, or -$6.66 to $42.18.

12:00 EDT Snap falls -19.0% - Snap is down -19.0%, or -$2.38 to $10.13.

12:00 EDT Teladoc rises 24.5% - Teladoc is up 24.5%, or $5.58 to $28.36.

11:54 EDT CD Projekt Red to lay off about 9% of its staff - CD Projekt Red CEO Adam Kicinksi said in a statement, "Those of you familiar with our strategy might remember that we have a lot going on at CD PROJEKT RED. Projects like Polaris (The Witcher franchise), Orion (Cyberpunk franchise), or Hadar (new franchise) are just some of the exciting elements in the future we see for our games. Part of that strategy is an ongoing process of several deep transformations within the studio which we consider key to making quality games, on time and without crunch. After reshaping our development process and incorporating Agile methodologies, we're now focusing on refining the shape of our teams. To meet our own high expectations and ambitions to create the best role-playing games, we not only want to have the best people but also the right teams. What we mean by that is having teams that are built around our projects' needs; teams that are more agile and more effective. At this point in time, we're certain that for CD PROJEKT RED to grow, we need to be consistent in implementing that approach. We've carefully assessed all teams in the company in terms of their expected contribution to the delivery of our strategy. There's no easy way to say this, but today we are overstaffed. We have talented people on board who are finishing their tasks and - based on current and expected project needs - we already know we don't have other opportunities for them in the next year. The outcome is the studio parting ways with around 100 people, which is roughly 9% of the entire team. This will not be immediate as some employees will be let go as late as Q1 2024 but, in the spirit of transparency, we've chosen to share the information now. We want team members to have ample time to process and adjust to the change, and we've also made sure to offer everyone a comprehensive severance package." Reference Link

11:49 EDT Bluejay Diagnostics Inc trading resumes

11:16 EDT CN to modernize 60 additional locomotives with Wabtec - CN (CNI) and Wabtec Corporation (WAB) announced an order to enhance an additional 60 locomotives in CN's existing fleet through Wabtec's modernization program. The investment supports CN's commitment to drive growth in a sustainable manner and build success for customers, employees and communities, the company said in a statement. "Modernizing these locomotives cost-effectively improves the reliability of our existing fleet and contributes to reducing our rail carbon footprint," said Mark Grubbs, Vice-President Mechanical at CN.

10:57 EDT Boeing sees commercial unit generating profit by year-end - Sees negative commercial margins for Q3.

10:52 EDT Boeing sees financial performance improving in 2H - Sees Q3 cash flow positive, in hundreds of millions of dollars.

10:49 EDT Boeing will take time to stabilize 737 at 38 per month rate, says CFO

10:43 EDT Boeing sees being in supply constrained world for 'foreseeable future'

10:39 EDT Boeing CEO: Spirit work stoppage, bridge impairment to delay 'few' deliveries

10:38 EDT Boeing CEO: Spirit stoppage, bridge issue to be contained in Q3

10:23 EDT Walmart, Expedia launch travel benefit for Walmart+ members - The companies said, "Walmart (WMT) is taking its valued Walmart+ members on a new, more rewarding journey before the summer travel season becomes this fall's show-and-tell. Beginning today, Walmart+ members can book getaways through WalmartPlusTravel.com and get Walmart Cash. Walmart+ members will receive 5% Walmart Cash on hotels, vacation rentals, car rentals and activities bookings, 2% Walmart Cash on all flights and a blended rate of Walmart Cash on vacation packages. Travel booking on WalmartPlusTravel.com is powered by Expedia Group's (EXPE) White Label Template technology, giving Walmart+ members access to more than 900,000 properties, 500+ airlines, 100+ car rental companies and thousands of activities around the world. This new offering will make shopping for travel a win-win for Walmart+ members as they begin getting Walmart Cash, previously Walmart Rewards, on all aspects of their vacation getaways."

10:05 EDT Blackbaud launches refreshed Blackbaud Partner Network - Blackbaud announced its refreshed Blackbaud Partner Network, which will deliver shared value for partners, customers and the company. Updates to the partner network will enable more partners to begin integrating their solutions with Blackbaud, with less time and effort required. New features of the refreshed program include: Automated onboarding that provides a streamlined and simplified way for partners to join; An online partner community that provides access to valuable resources, news and announcements from Blackbaud and engagement with other partners; A new learning management system coming soon that is designed specifically for partners and includes a large library of on-demand training. These updates will enable Blackbaud to reduce barriers to entry and democratize access to its partner network, with no cost to partners. With these updates, the program has seen notable growth, with Blackbaud adding more than 40 partners in just the last quarter.

10:01 EDT Lockheed Martin selected to develop nuclear-powered spacecraft - Lockheed Martin has won a contract from the Defense Advanced Research Projects Agency to develop and demonstrate a nuclear-powered spacecraft under a project called Demonstration Rocket for Agile Cislunar Operations. The project will represent a rapid advancement in propulsion technology to benefit exploration and national defense. DARPA partnered with NASA's Space Technology Mission Directorate on the DRACO project, as both agencies will benefit from this leading edge technology. The in-space flight demonstration of a nuclear thermal rocket engine vehicle will take place no later than 2027.

10:00 EDT Silgan Holdings falls -12.6% - Silgan Holdings is down -12.6%, or -$6.16 to $42.68.

10:00 EDT Teladoc rises 14.4% - Teladoc is up 14.4%, or $3.27 to $26.05.

10:00 EDT XPeng rises 28.6% - XPeng is up 28.6%, or $4.40 to $19.76.

09:47 EDT RPC, Inc. falls -9.9% - RPC, Inc. is down -9.9%, or -88c to $8.08.

09:47 EDT Snap falls -19.0% - Snap is down -19.0%, or -$2.38 to $10.13.

09:47 EDT Western Alliance rises 11.1% - Western Alliance is up 11.1%, or $5.25 to $52.44.

09:42 EDT Dish Network trading resumes

09:37 EDT Dish Network trading halted, volatility trading pause

09:27 EDT Maximus sees personal information of 'significant number' exposed due to MOVEit - In a regulatory filing, Maximus (MMS) stated: "On May 31, 2023, Progress Software Corporation, the developer of MOVEit, a file transfer application used by many organizations to transfer data, announced a critical zero-day vulnerability in the application that allowed unauthorized third parties to access its customers' MOVEit environments. It appears that a significant number of commercial and government customers worldwide were affected by this vulnerability. Maximus uses MOVEit for internal and external file sharing purposes, including to share data with government customers pertaining to individuals who participate in various government programs. The company believes that the personal information of a significant number of individuals was accessed by an unauthorized third party by exploiting this MOVEit vulnerability. The company is cooperating with law enforcement regarding this cybersecurity incident. Maximus promptly commenced an investigation of the incident with the assistance of outside legal, forensic and data analytics experts and has taken remedial steps to address the reported vulnerabilities. The company's forensic expert has completed the forensic aspects of the investigation, which has identified the files impacted by the cybersecurity incident. The company's review of these files is ongoing. At present, there is no indication that the incident has had any impact on the internal information technology systems of the company or its customers beyond the MOVEit environment, and there has been no material interruption to the company's business operations due to the incident. Based on the review of impacted files to date, the company believes those files contain personal information, including social security numbers, protected health information and/or other personal information, of at least 8 to 11 million individuals to whom the company anticipates providing notice of the incident. The company has been notifying its customers as well as federal and state regulators, and it will provide appropriate notifications to individuals affected by this incident. In addition, individuals receiving notice will be offered free credit monitoring and identity restoration services. Maximus currently plans to record an expense of approximately $15M for the quarter ended June 30, 2023 representing the company's best estimate of the total investigation and remediation activities to be incurred related to the incident. The information provided in this Current Report on Form 8-K, including the estimated number of impacted individuals and estimated expenses, is preliminary and is based on currently available information and is subject to change during the course of the company's ongoing investigation of the cybersecurity incident. The company's review of impacted files is ongoing, and the company is unable to predict the total number of impacted individuals who will receive notice of the incident until that review is completed, which we expect will not be for several more weeks. The company is also unable to predict other potential liabilities or consequences that may arise from this incident. As the investigation progresses, additional information may become available that could cause the company's estimates and preliminary determinations to change."

09:23 EDT BWX Technologies to provide nuclear reactor engine fuel for DARPA space project - BWX Technologies (BWXT) announced that its reactor and fuel will be key components in the world's first demonstration spacecraft using nuclear thermal propulsion. Working as part of a team led by Lockheed Martin, BWXT Advanced Technologies will complete final design of the nuclear reactor, manufacture the reactor's hardware and fuel, assemble the components and deliver the fueled reactor as a complete subsystem for integration into the Defense Advanced Research Projects Agency's or DARPA, Demonstration Rocket for Agile Cislunar Operations, known as DRACO..."The award of this contract further demonstrates BWXT's ability to design, manufacture and deploy nuclear reactors and fuel on a scale that is unmatched elsewhere in the world today," said Joe Miller, president of BWXT Advanced Technologies . "This partnership with Lockheed Martin (LMT) working for DARPA adds another important dimension to BWXT's already-impressive line-up of nuclear reactor designs for commercial and defense applications."

09:17 EDT Jiuzi Holdings regains compliance with Nasdaq minimum bid price rule - Jiuzi Holdings received a notification letter from the Nasdaq Listing Qualifications Staff of The NASDAQ Stock Market notifying the Company that it has regained compliance with the Nasdaq's minimum bid price requirement and the matter is closed. On July 26, 2022, the Company was first notified by Nasdaq its failure to maintain a minimum bid price of $1.00 per share for 30 consecutive business days under Nasdaq Listing Rules 5550(a)(2) and 5810(c)(3)(A), and on January 23, 2023 the Company received a 180-day extension from Nasdaq or until July 24, 2023 to regain compliance. Effective July 10, 2023, the Company effected an eighteen-to-one reverse split of its ordinary shares, which was reflected with Nasdaq and in the marketplace at the opening of business on July 10, 2023. The letter the Company received from Nasdaq on July 24, 2023 noted that as of July 21, 2023, the Company evidenced a closing bid price of its ordinary shares at or greater than the $1.00 per share minimum requirement for the last 10 consecutive business days, from July 10, 2023 through July 21, 2023. Nasdaq stated that accordingly, the Company has regained compliance with Nasdaq Listing Rule 5550(a)(2).

09:12 EDT Coca-Cola: Inflationary pressures beginning to moderate in some ways - Costs of several commodities like sugar and juice remain elevated

09:09 EDT General Dynamics says all segments grew y/y in Q2, with defense rising by 12% - Reports sequential and year-over-year growth at Aerospace. Says "relief in sight" for supply chain issues. Says "well positioned" for 2H23. Expects higher CapEx in 2H23. Comments taken from Q2 earnings conference call.

09:08 EDT Clever Leaves announces its Colombian Flower available in Australia - Clever Leaves announced that its Colombian flower is now available to patients in Australia through a partnership with Australian Natural Therapeutics Group. The products are available to medical patients in Australia under ANTG's "Global Selects" brand portfolio. "As Australia's medical market continues to grow, working with ANTG marks a significant milestone for us. We are committed to facilitating access to our Colombian flower for those seeking to enhance their quality of life through medicinal products cultivated in our country," said Andres Fajardo, CEO of Clever Leaves. "Our working relationship with ANTG has been exceptional, as a renowned company for its commitment to research, certified quality standards, and distribution capabilities, all in line with our goal to produce the highest quality, cannabinoid-based products for medical patients worldwide."

09:07 EDT Sarcos awarded AI contract by Air Force Research Laboratory - Sarcos Technology and Robotics Corporation announced the award of an expanded contract FA8750-22-C-1005 from the Air Force Research Laboratory AFRL for continued development of artificial intelligence -driven methods and techniques that autonomously control a Heterogeneous Sensing Network HSN . As part of the AFRL contract, Sarcos is developing a collaborative sensing solution that enables its Department of Defense or DoD partners to quickly, accurately, and safely identify, track, and classify time-critical objects using autonomous, heterogeneous sensor networks and AI to improve the operations, safety, data collection, and communication of autonomous platforms, such as Unmanned Aircraft Systems or UASs, and Unmanned Aerial Vehicles or UAVs. "Sarcos' unique approach to reinforced learning and AI enables autonomous systems to work together more effectively," said Dr. Peter Zulch, AFRL. "Sarcos utilizes advanced AI-driven methods and techniques to improve the operations, safety, data collection, and communication of our autonomous platforms." The methods developed will harness the power of a myriad of sensor data to create more robust data sets that enable accurate autonomous operations in dynamic and unstructured environments, such as subsea operations and solar panel installations over diverse terrain, and the application for air force systems. The approach models how humans detect and adapt to their surroundings - using the multiple senses of sight, sound, and feel - to make real-time decisions and adjustments to operate effectively in real-world environments. "This continued work is

09:06 EDT Volkswagen to invest $700M in XPeng, jointly develop EVs in China - The Volkswagen Group (VWAGY) said it is "strengthening its position on the Chinese automotive market" with cooperations between the VW brand and XPENG (XPEV) and between Audi and SAIC. "The Group is thus forging ahead with its local electrification strategy. The aim is to swiftly tap into new customer and market segments, thereby systematically leveraging the potential of China's dynamically growing e-mobility market," VW stated. "The VW brand has concluded a technological framework agreement with XPENG. The initial stage of the cooperation shall provide for the joint development of two VW brand electric models for the mid-size segment in the Chinese market. The China-specific vehicles will supplement the MEB product portfolio and are to be rolled out in 2026 in China. This is subject to the conclusion of final agreements. As part of the close and long-term strategic cooperation, the Volkswagen Group is to invest approximately US $700Min the Chinese manufacturer of intelligent electric cars. Volkswagen is thus acquiring 4.99% stake in XPENG at US $15 per ADS by way of a capital increase, and will hold a seat as an observer on the XPENG board of directors. The share issuance will be subject to customary closing conditions including applicable regulatory approvals. Audi has signed a strategic memorandum with its Chinese joint venture partner SAIC to further expand existing cooperation. Joint development activities are to extend the portfolio of fully connected electric vehicles on offer in the premium segment swiftly and efficiently. It is planned to start with electric models in a segment where Audi does not as yet have a presence in China," VW said. Reference Link

09:05 EDT Paylocity unveils new products, features for HCM industry - Paylocity announced new premium products and feature enhancements designed to drive greater productivity, enhance the employee experience, and improve business outcomes in its Human Capital Management solution. Market Pay is a new premium product that provides comprehensive market pay data to help organizations pay their employees fairly, attract and retain top talent, and maintain compliance with laws and regulations-all in real time and directly within the Paylocity platform. Using Market Pay, Paylocity clients can make better compensation decisions, evaluate specific roles accurately, and comply with pay equity and job posting requirements in multiple states. Advanced Scheduling premium functionality improves workforce management by enabling organizations to further automate scheduling, reduce labor costs, and minimize compliance risks. Businesses can build schedules for multiple locations by matching the most suitable employees based on job function or role, skill set, and certifications. The new functionality also includes real-time insights to help ensure the right coverage and minimize overtime expenses by anticipating hours needed for future shifts and enabling employers to identify employees who are approaching or have already reached overtime thresholds. Learning Management System is a training platform that enables Paylocity clients to easily assign courses that cover new skills, policies, products, compliance, and other topics, with robust tracking capabilities. The latest enhancements to Paylocity's LMS enable employees to create training content - including videos - and then easily share it via Community. Generative AI debuted in the HCM industry for the first time on the Paylocity platform in April 2023, appearing as an embedded feature in Community, Paylocity's online collaboration hub. By responding to a user prompt that outlines simple details like what they want to communicate, the target audience, and desired tone, the AI tool generates polished and professional messages, saving valuable time and effort.

09:04 EDT ON Semiconductor secures $1.95B in long-term supply agreements - ON Semiconductor announced it has secured $1.95B in long-term supply agreements, or LTSAs, for its intelligent power technologies with leading global manufacturers of solar inverters.

09:03 EDT Micron begins sampling 8-high 24GB HBM Gen2 memory - Micron Technology has begun sampling the industry's first 8-high 24GB HBM3 Gen2 memory with bandwidth greater than 1.2TB/s and pin speed over 9.2Gb/s, which is up to a 50% improvement over currently shipping HBM3 solutions. With a 2.5 times performance per watt improvement over previous generations, Micron's HBM3 Gen2 offering sets new records for the critical artificial intelligence data center metrics of performance, capacity and power efficiency. These Micron improvements reduce training times of large language models like GPT-4 and beyond, deliver efficient infrastructure use for AI inference and provide superior total cost of ownership

09:01 EDT Microsoft integrates PayPal's Pay Later solution in several countries - PayPal Holdings (PYPL) and Microsoft (MSFT), announced Microsoft's integration of PayPal's Pay Later solution in the U.S., U.K., Australia, Germany, France, Spain, and Italy. In addition, customers in the U.S. will soon have the option to pay with Venmo in the Microsoft Store. Venmo is currently available in the Microsoft Store on Xbox in the U.S. These new integrations offer customers more flexible ways to pay and help increase customer loyalty.

09:01 EDT Volkswagen to invest $700M in XPeng, jointly develop EVs in China

08:53 EDT AT&T expects to move past peak CapEx by end of year - Sees CapEx ~$1B lower in 2H23 vs. 1H23. Says fiber revenue "outpacing" legacy revenue. Expects this trend to continue. "Feels good" about plans to de-lever.

08:48 EDT China's SAMR approves Silicon Motion acquisition by MaxLinear with conditions - A translated notice by China's State Administration for Market Regulation, or SAMR, announces approval of the acquisition of shares of Huirong Technology Co. by Mailing Company with "additional restrictive conditions." Reference Link

08:47 EDT Healthcare Triangle reports initial interest in ransomware initiative - Healthcare Triangle announced that its new ransomware prevention and protection initiative launched earlier this month is drawing initial interest and support from numerous health system clients seeking critical tools and guidance for preventing and responding to ransomware incidents. The Company is servicing multiple contract agreements for cloud backup and disaster recovery, enabling hospitals and health systems to move disaster recovery to the Amazon Web Services cloud to secure resources and scale on demand. This helps to mitigate risks by increasing resilience and meeting compliance requirements. Elastic disaster recovery minimizes downtime with minimal RPO and RTO for immediate recovery to ransomware events. "The accelerating volume of national news about ransomware incidents is driving widespread demand for cybersecurity services. Our clients are seeking guidance and protection from solutions that are specific to the concerns and needs of healthcare systems and their patients," said Lena Kannappan, head of business, strategy and partnerships for Healthcare Triangle. In July alone, one of the country's largest providers confirmed a data breach impacting 11 hospitals and 12 million patients, and now faces at least four class action lawsuits. A prominent community hospital had to close its doors permanently due to a 2021 ransomware attack that caused devastating financial loss. IBM reported that 'the average costs of a studied breach in healthcare reached nearly $11 million in 2023 - a 53% price increase since 2020.'

08:43 EDT Muscle Maker announces name change, rebranding to Sadot - Muscle Maker announced its corporate rebranding from MMI to Sadot Group Inc. effective July 27, 2023. The Company's stock ticker symbol will change from "GRIL" to "SDOT" on the Nasdaq stock exchange, and trading under the new stock ticker symbol will commence on July 27. Holders of common stock are not required to exchange current outstanding stock certificates for new stock certificates. The parent company name change was initiated by the Company's strategic pivot into the global agri-food supply chain industry. Since the pivot in November 2022, the company has delivered consistent results. As of June 30, 2023, Sadot LLC, a wholly-owned subsidiary, crossed the $500 million total revenue milestone since its inception. The Company has now exceeded $45 million in monthly revenue for eight consecutive months. In addition to high revenues month after month, the Company recently announced the expansion into new trade routes throughout North, Central and South America along with the purchase and initiation of farming operations in Zambia, keeping the Company on its trajectory to reach its goals of becoming a significant global presence in the sector.

08:42 EDT AT&T says FY23 results 'tracking entirely' with guidance - Says customers "very happy" with network quality. Expects to reduce net debt by ~$4B by end of 2023, with net debt-to-adjusted EBITDA of 3.0x. On track to reach 2.5x range in first half of 2025. Sees about $11B in free cash flow in 2H23. Expects to increase cash generation over time. Going forward, expects majority of cash after dividends to go towards debt reduction. Comments taken from Q2 earnings conference call.

08:41 EDT Nexalin Technology establishes 'Nexalin America' public sector division - Nexalin Technology announced the formation of a new division, to be called "Nexalin America," aimed at fostering relationships within the U.S. Department of Defense, U.S. Department of Veterans Affairs, and U.S. Department of Health and Human Services. Nexalin America will focus on engaging and collaborating with these U.S. government agencies in order to enable their personnel to have access to, and benefit from, Nexalin's non-invasive, frequency-based, deep-brain stimulation devices. Nexalin anticipates the U.S. government's use of its groundbreaking technology to treat PTSD, traumatic brain injury, anxiety, depression, insomnia and other targeted indications. As part of its strategy in forming Nexalin America, the Company also announced that it has retained industry and government affairs veteran, Ryan Kane, CEO of RK Strategies, Inc., to support and lead "Nexalin America."

08:39 EDT Versus Systems granted additional extension to regain compliance with Nasdaq - Versus System announced that it has received an additional extension of 180 calendar days from The Nasdaq Stock Market to regain compliance with the minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on the Nasdaq Capital Market. The extension follows the expiration of the initial 180 calendar day compliance period on July 24, 2023. As a result of the extension, Versus now has until January 22, 2024 to regain compliance with the Bid Price Requirement. If at any time before January 22, 2024, the bid price of the Company's common shares closes at or above US$1.00 per share for a minimum of 10 consecutive business days, Nasdaq will provide written notification to Versus that it has achieved compliance with the Bid Price Requirement.

08:38 EDT Ageagle Aerial Systems provides update on introduction of eBee VISION - AgEagle Aerial Systems issued an update on the Company's global market introduction of its latest drone innovation, the eBee VISION - the next generation in Intelligence, Surveillance and Reconnaissance unmanned aerial systems featuring live, 4-K resolution video imagery from a distance of up to 12 miles. In support of its sales and pre-order efforts, AgEagle's team has been engaged in numerous live demonstrations and intensive training sessions with officials from government and military agencies across the world seeking to leverage the power of eBee VISION in their respective drone operations. In July alone, AgEagle completed a comprehensive training session with its first European military customers, who were confirmed as eBee VISION operators and qualified trainers of new users. These new customers confirmed with AgEagle's technical teams that all operational capabilities of the eBee VISION continue to meet and exceed performance benchmarks in scouting, surveillance, usability, fast deployment and flight time, among other use case criteria specified by the international military community. The Company has also been working in close collaboration with its network of valued added reselling partners in France, United Kingdom, Poland, Italy and Spain, among other countries, to conduct live demonstrations and technical exchanges with prospective new customers, with emphasis on showcasing use of eBee VISION UAS for public safety and first responder missions, border patrol and a wide range of commercial applications. In the coming months, AgEagle will be showcasing the eBee VISION at numerous industry events, conferences and shows, including the Commercial UAV Expo 2023 in Las Vegas in September, DSEI 2023 in London in September, and Milipol Paris 2023 in Paris, France in November.

08:36 EDT Conifer Holdings announces extension of exchange offer - Conifer Holdings extended its offer to exchange its outstanding 6.75% Senior Unsecured Notes due 2023 for 9.75% Senior Unsecured Notes due 2028 to be issued by the Company. The Company also is offering up to $25,000,000 in aggregate principal amount of New Notes for cash, which are being offered on a reasonable best efforts basis and are still available for purchase. The Exchange Offer, which was previously scheduled to expire at 5:00 p.m., New York City time, on July 25, 2023, will now expire at 6:00 p.m., New York City time, on August 1, 2023, unless earlier terminated or extended by the Company. Any Existing Notes tendered may be withdrawn at any time prior to the Expiration Date, but not thereafter. Except for the extension of the Expiration Date and Withdrawal Deadline, all other terms of the Exchange Offer remain in full force and effect. Janney Montgomery Scott and American Capital Partners, LLC are serving as dealer managers for the Exchange Offer and placement agents for the New Offering. Conifer Holdings said it has been informed by the dealer managers and placement agents that, as of July 25, 2023 at 5:00 p.m., New York City time, approximately $5.2 million in aggregate principal amount of the Existing Notes had been tendered in the Exchange Offer, which amount represents approximately 21.5% of the Existing Notes. The New Notes are being issued pursuant to a registration statement on Form S-4 and Form S-1, as amended, including a prospectus, which was filed with the Securities and Exchange Commission which was declared effective by the SEC. The Company has applied for the New Notes to be listed on the Nasdaq Global Market under the ticker symbol "CNFRZ".

08:35 EDT NeoGames' Pariplay has expanded in South Africa, partners with SunBet - NeoGames announced that its subsidiary Pariplay has expanded in South Africa following a key strategic partnership with SunBet. The agreement will see the tier-one African operator supplied with certified content from both the proprietary Wizard Games brand, as well as 3rd party content from the Fusion platform. Tsachi Maimon, President at NeoGames, said: "Sun International is one of the most well-known casino brands in the African continent, offering incredible land-based as well as online play - through SunBet - for its customers. We're delighted to partner with them to bring not only Fusion aggregation content but also home-grown Wizard Games products to further elevate their players' array of choice on an interesting and fast-growing regulated market."

08:35 EDT Coca-Cola CEO: June was strongest month in Q2 - CEO James Quincey says Coca-Cola has headroom to grow volume and value. Comments taken from Q2 earnings conference call.

08:33 EDT LianBio partner Tarsus announces U.S. FDA approval of XDEMVY - LianBio's (LIAN) partner, Tarsus Pharmaceuticals (TARS), announced yesterday that the U.S. Food and Drug Administration approved XDEMVY 0.25% for the treatment of Demodex blepharitis. XDEMVY, formerly known as TP-03, is the first and only FDA approved treatment to directly target Demodex mites, the root cause of Demodex blepharitis. LianBio in-licensed rights from Tarsus for the development and commercialization of TP-03 for Demodex blepharitis and Meibomian Gland Disease in Mainland China, Hong Kong, Macau and Taiwan. LianBio is currently conducting the LIBRA trial. LianBio expects to report topline results from LIBRA in the fourth quarter of 2023. "We congratulate Tarsus on receiving U.S. FDA approval of XDEMVY for the treatment of Demodex blepharitis," said Yizhe Wang, Ph.D., Chief Executive Officer of LianBio. "XDEMVY is the only approved drug in the United States that targets the root cause of Demodex blepharitis, a disease that impacts an estimated 43 million patients in China. We look forward to concluding our LIBRA study this year, and if the data are positive, submitting a New Drug Application to support regulatory approval in China."

08:26 EDT AT&T 'confident' in FY23 free cash flow of '$16B or better' - Reports Q2 free cash flow of $4.2B, up $1B in first-half 2023 compared to first-half 2022; confident in full-year free cash flow of $16B or better. "The direction we set three years ago is sound, and we're on the right trajectory," said John Stankey, AT&T CEO.

08:23 EDT Bragg Gaming in distribution deal with betting firm 888 Holding - Bragg Gaming Group is pleased to announce the signing of a new global distribution agreement with 888 Holdings, The new agreement further strengthens the companies' existing collaboration. Under the new agreement, Bragg's exclusive content is expected to roll out with William Hill in the UK, Mr Green in Italy, Sweden and Denmark, and 888casino in Italy for the first time, following launches with the operator in the UK, Spain and Ontario over the course of the last year. This collaboration further enhances the distribution of Bragg's proprietary and exclusive content in multiple regulated markets, offering a wide array of exclusive and popular titles from Bragg Studios brands such as Atomic Slot Lab and Indigo Magic, as well as from its Powered by Bragg partners.

08:19 EDT Amneal Pharmaceuticals submits ANDA to FDA for three key complex generics - Amneal Pharmaceuticals announced it has submitted Abbreviated New Drug Applications to the U.S. Food and Drug Administration for three key complex generic products, including: IQVIA, Albuterol sulfate inhalation Bimatoprost ophthalmic solution, Propofol emulsion .."We continue to make excellent progress advancing our pipeline of complex, high-value medicines. The filing of applications for three new complex generics are additional proof points in our successful innovation journey. Today, about 90% of our generics R&D pipeline is made up of complex products. As we move up the value chain of product complexity, we are adding new and sustainable long-term growth drivers to our diversified portfolio," said Chirag and Chintu Patel, Co-Chief Executive Officers.

08:18 EDT AT&T reports Q2 cash from operating activities $9.9B, up 28.2% y/y - Up $1.2B in first-half 2023 compared to first-half 2022.

08:16 EDT AT&T 'confident' in FY23 free cash flow of '$16B or better' - Reports Q2 free cash flow of $4.2B, up $1B in first-half 2023 compared to first-half 2022; confident in full-year free cash flow of $16B or better. "The direction we set three years ago is sound, and we're on the right trajectory. Compared to last year, Mobility service and broadband revenues are up, Adjusted EBITDA is up, free cash flow is up, Mobility and Consumer Wireline margins are up and customer lifetime values are up," said John Stankey, AT&T CEO. "We're focused on growing the right way, adding profitable 5G and fiber customers. We are also committing to an incremental $2 billion-plus in cost savings beyond the $6 billion we have accomplished over this period, reflecting our continued march to operating the company in a more focused and streamlined fashion. Our results give us full confidence in delivering our full-year financial guidance."

08:12 EDT Oryzon Genomics completes patient recruitment in PORTICO Phase IIb trial - Oryzon Genomics reports that full patient recruitment has been completed in its ongoing Phase IIb PORTICO trial, investigating vafidemstat in Borderline Personality Disorder. PORTICO is a global double blind, randomized, placebo-controlled, adaptive 14-week Phase IIb trial evaluating the efficacy and safety of vafidemstat in a BPD population. The trial has multiple primary endpoints: reduction of agitation and aggression and overall disease improvement in BPD severity. The trial recruited patients in the US, Germany, Spain, Bulgaria and Serbia, and aims to analyze 150 patients who complete the trial, randomized in two arms at a 1:1 ratio. The last patient out is expected before the end of 2023. Topline results are expected in Q1 2024, followed by a full data presentation at a psychiatric conference, as well as in a peer-reviewed journal publication. The independent Data Monitoring Committee met routinely and reviewed the safety data throughout the PORTICO trial. The last analysis corresponded to the initial 167 randomized patients and the DMC recommended continuing the trial without modifications until full enrollment. Current safety data of PORTICO are aligned with previous vafidemstat trials and continue to support that vafidemstat is safe and well-tolerated. PORTICO has an adaptive design with a pre-defined interim analysis to assess the signal size and futility. This predefined IA was done with the data of the first 90 patients that had concluded at least two-thirds of the trial. The outcome of this IA was that PORTICO was not futile and should continue as it is without increasing the number of patients to be recruited.

08:11 EDT Elys Game launches ELYS Sportsbook partnership with Santa Claran Casino resort - Elys Game Technology announced the opening of the Sports Book at Santa Claran Casino Resort situated at 460 N Riverside Dr, in Espanola, New Mexico. The Company's subsidiary Elys Gameboard Technologies is providing betting technology and bookmaking services to Santa Claran. The opening of this sportsbook represents continuous expansion of Elys' footprint in regulated U.S. markets and one of the first Elys America branding initiatives.

08:09 EDT AbbVie announces publication of results from Phase 4 IMMpulse study - AbbVie announced the British Journal of Dermatology published results from the head-to-head Phase 4 IMMpulse study that evaluated the efficacy and safety of SKYRIZI, or risankizumab, compared to Otezla, or apremilast, among adult patients with moderate plaque psoriasis eligible for systemic therapy.1 This study achieved all primary and ranked secondary endpoints with no new safety signals identified. Highlights from this open-label, efficacy assessor-blinded study include: at Week 16, a significantly higher proportion of patients who received risankizumab achieved the Period A co-primary endpoints of Psoriasis Area and Severity Index, or PASI, 90 and Static Physician's Global Assessment, or sPGA, 0/1, the proportion of patients achieving the ranked secondary endpoint of PASI 75 at Week 16 was also significantly higher in risankizumab- versus apremilast-treated patients. The safety profile for risankizumab in this study was consistent with previously reported studies; it was well-tolerated with no new safety signals identified. SKYRIZI is part of a collaboration between Boehringer Ingelheim and AbbVie, with AbbVie leading development and commercialization globally.

08:08 EDT Ocuphire Pharma schedules End-of-Phase 2 meeting with FDA for APX3330 - Ocuphire Pharma announced that results from the ZETA-1 Phase 2 trial evaluating APX3330 in diabetic retinopathy will be presented at the American Society of Retinal Specialists annual scientific meeting to take place in Seattle, Washington, July 28 to August 1. In addition, Ronil Patel, MTech, MS, SVP of Operations & Business Development at Ocuphire, will provide a corporate update at the OIS Retina Innovation Summit on July 27, also in Seattle, Washington. Ocuphire also announced that it has scheduled an End-of-Phase 2 meeting with the FDA in Q4 2023 to discuss the specifics of the APX3330 development program. In the ZETA-1 trial, APX3330 achieved statistical significance in preventing clinically meaningful progression of diabetic retinopathy, as measured by the percentage of subjects with binocular greater than or equal to3-step worsening in DRSS, the anticipated Phase 3 primary endpoint. "APX3330 is the most advanced oral program currently in development for diabetic retinopathy, and the End-of-Phase 2 meeting confirmed for Q4 2023 is a critical milestone for our development program," said Rick Rodgers, Interim CEO of Ocuphire. "Currently, patients with non-proliferative diabetic retinopathy are not treated due to the lack of non-invasive options on the market and the monthly time burden required for intravitreal injections. Eighty percent of physicians prefer to use a wait-and-see approach for these patients rather than delivering a monthly biologic treatment where patients often become incomplete responders. If approved, APX3330 has the potential to shift the treatment paradigm and be the first non-invasive, oral, early treatment for the 8 million NPDR patients who are at risk of progressing to vision-threatening complications. We look forward to working with the FDA to confirm the Phase 3 study design and advancing APX3330 towards a potential NDA submission."

08:05 EDT Humacyte completes enrollment in Phase 2/3 trial of HAV - Humacyte announced completion of enrollment of its Phase 2/3 vascular trauma trial, V005, that is expected to support a BLA filing for Humacyte's Human Acellular Vessel, HAV, in vascular trauma repair. The HAV is designed to provide surgeons with an off-the-shelf bioengineered human artery that has been observed to repopulate with the patient's own cells to provide a durable, infection-resistant replacement for damaged and diseased arteries. The results from the Phase 2/3 vascular trauma trial are intended to support a BLA filing with the Food and Drug Administration, FDA, planned for the fourth quarter 2023. "We believe that the HAV could revolutionize the ability of surgeons to save the lives and limbs of patients suffering vascular injuries, not only in civilian settings, but also in more challenging environments like the battlefield," said Dr. Laura Niklason, CEO of Humacyte. "The completion of the target enrollment in Humacyte's Phase 2/3 vascular trauma trial is expected to enable BLA submission, and is another important landmark moment for our groundbreaking science. Our regenerative medicine technologies create dramatic new therapies - with the potential to provide treatment options for patients facing loss of life or limb for whom current therapies are either inadequate or not available."

08:04 EDT Boost Infinite brings its $25/month unlimited postpaid plan to Amazon.com - Boost Infinite is bringing its Infinite Unlimited wireless postpaid plan to Amazon (AMZN) with an exclusive offer for Prime members. Amazon Prime members who purchase the Boost Infinite Unlimited SIM kit in the Amazon U.S. store will get 20% off the list price of $25, on top of a $25 bill credit toward their first month of service from Boost Infinite. The SIM kit, sold and shipped fast for free by Amazon, enables Prime members to activate Infinite Unlimited wireless service that includes unlimited talk, text, and data for only $25 a month-a price that's locked forever. Prime members are automatically pre-qualified for Boost Infinite's plan, which is compatible with most unlocked iPhones and Android smartphones. Subscribers may add up to five lines per account. Boost Infinite is a retail wireless carrier under DISH Wireless, a subsidiary of DISH Network (DISH).

08:02 EDT DZS introduces DZS FiberWay broadband solutions - DZS introduced DZS FiberWay - the industry's first end-to-end, environmentally hardened fiber broadband solutions specifically designed to bridge the digital divide. Architected to meet the unique challenges of middle mile and last mile fiber networks both today and in the future, DZS FiberWay empowers service providers leveraging broadband stimulus programs to invest in solutions across the access, optical, subscriber and cloud edge that position them for sustainable success long after the awarded funds are spent.

07:48 EDT Union Pacific reports Q2 operating ratio 63%, up 280 bps y/y - This includes an unfavorable 110 basis point impact from a one-time labor agreement payment and a 200 basis point benefit from falling fuel prices. Business volumes, as measured by total revenue carloads, were down 2%. Operating income of $2.2B declined 12%.

07:46 EDT Draganfly to introduce Precision Delivery System as flag bearer at WPFG - Draganfly will introduce its new Precision Delivery System as the world's first drone to be the official flag bearer during its attendance at the World Police and Fire Games in Winnipeg, Manitoba, from July 28 to August 6, 2023. Draganfly's Precision Delivery System was granted a Special Flight Operations Certificate for a Remotely Piloted Aircraft System.The SFOC-RPAS authorization signifies that Draganfly's technology has met stringent safety and operational standards, granting the Company permission to conduct drone flights beyond the confines of basic or advanced operations.

07:42 EDT Inozyme finalizes trial design for ENERGY-3 trial of INZ-701 - Inozyme Pharma announced a regulatory update for its global development strategy of INZ-701 for the treatment of ENPP1 Deficiency following recent meetings with the United States Food and Drug Administration and the Paediatric Committee of the European Medicines Agency. The Company plans to initiate the ENERGY-3 pivotal trial, a multicenter, randomized, open label trial in pediatric patients with ENPP1 Deficiency in October 2023. The ENERGY-3 trial is expected to enroll up to 33 patients between the ages of one and less than 13 years across multiple sites globally and is designed primarily to assess the efficacy and safety of INZ-701 in pediatric patients with ENPP1 Deficiency. Enrollment criteria for the trial include a confirmed genetic diagnosis of ENPP1 Deficiency, radiographic evidence of skeletal abnormalities and low plasma PPi. Patients will be randomized in a 2:1 ratio to an INZ-701 arm or a control arm for 52 weeks, followed by an open label extension period during which all patients may receive INZ-701. INZ-701 will be administered at a 2.4 mg/kg once weekly dose via subcutaneous injection. ENERGY-3 is a single, multicenter, clinical trial with differences in the statistical treatment of endpoints, based on guidance from the FDA and PDCO, as follows: U.S. Primary Endpoint - Change in plasma PPi from baseline; Secondary Endpoints - RGI-C score, Rickets Severity Score, Growth Z-score and pharmacokinetics. EU Co-Primary Endpoints - Change in plasma PPi from baseline and Radiographic Global Impression of Change score; Secondary Endpoints - RSS, Growth Z-score and PK. Based on recommendations from the FDA, the primary endpoint of plasma PPi should be supported by consistent trends in appropriate secondary endpoints. Based on the agreed Paediatric Investigational Plan with PDCO, plasma PPi and RGI-C are co-primary endpoints, with a relaxed p-value of less than0.2 for RGI-C. The Company plans to conduct the ENERGY-2 pivotal trial, an open label, single arm trial in infants with ENPP1 Deficiency, based on the Paediatric Investigational Plan agreed upon by PDCO. The trial is expected to be initiated outside of the U.S. The trial's co-primary endpoints will be change in plasma PPi from baseline and survival. The trial is expected to enroll up to 12 infants between birth and up to 12 months of age. Primary endpoint data from this trial will be compared to a natural history control group with patients matched on covariates associated with mortality. Discussions are ongoing with the FDA regarding the design of a potential pivotal trial of INZ-701 in infants with ENPP1 Deficiency in the U.S. Pending regulatory discussions and appropriate financial resources, the Company also plans to conduct the ENERGY-4 pivotal trial, a multicenter, randomized, controlled trial in adolescents and adults with ENPP1 Deficiency. In the U.S., the trial's sole primary endpoint is expected to be change in plasma PPi from baseline, supported by trends in appropriate secondary endpoints, and in the EU, the trial's co-primary endpoints are expected to be change in plasma PPi from baseline and bone mineral content/density. Subject to regulatory review, the trial is expected to enroll up to 30 patients 13 years and older, and patients will be randomized in a 2:1 ratio to an INZ-701 arm or a control arm. Based on regulatory feedback from the FDA and EMA, positive data from the ongoing and planned clinical trials of INZ-701 in patients with ENPP1 Deficiency, including comprehensive data demonstrating clinical impact of plasma PPi, could provide the basis for the Company's submission of marketing applications in both the U.S. and EU. These data will include final results from the Company's ongoing Phase 1/2 trial in adult patients with ENPP1 Deficiency, available results from the Company's ongoing ENERGY-1 trial, a Phase 1b trial of INZ-701 in infants with ENPP1 Deficiency, available results from the planned pivotal ENERGY-2 trial in infants to be initiated ex-U.S., and final results from the planned pivotal ENERGY-3 trial in pediatric patients. If these marketing applications are approved, the Company expects to commercially launch INZ-701 for infant and pediatric patients as early as the second half of 2026. Data from the planned ENERGY-4 trial in adolescent and adult patients with ENPP1 Deficiency may provide a basis for a supplemental marketing application. Anticipated Milestones for ENPP1 Deficiency Program: Interim data from Cohorts 1-3 in the Phase 2 portion of the ongoing Phase 1/2 trial in adults - September 2023; Initiation of ENERGY-3 trial, a pivotal trial in pediatric patients - October 2023; Topline data from Cohorts 1-3 in the Phase 2 portion of the ongoing Phase 1/2 trial in adults - Q1 2024; Initiation of ENERGY-2 trial, a pivotal trial in infants, ex U.S. - Q2 2024; Interim data from ENERGY-1 trial, a Phase 1b trial in infants - 2H 2024; Topline data from ENERGY-3 trial, a pivotal trial in pediatric patients - Mid-2025.

07:39 EDT Monte Rosa Therapeutics appoints Manning to board of directors - Monte Rosa Therapeutics (GLUE) announced the appointment of Anthony Manning, Ph.D., to its Board of Directors. Dr. Manning serves as a Board Director for Palatin Technologies (PTN), Founder and Chair of the non-profit Institute for Biomedical Entrepreneurship, and Scientific Advisor for several companies. Most recently, Dr. Manning was Chief Scientific Officer at Momenta Pharmaceuticals.

07:37 EDT Boeing targets 737 production of 50 per month in 2025/2026 timeframe - The 737 program is transitioning production to 38 per month and plans to reach 50 per month in the 2025/2026 timeframe. The program still expects to deliver 400-450 airplanes this year. The 787 program increased production to four per month with plans to ramp to five per month in late 2023 and 10 per month in the 2025/2026 timeframe. The program still expects to deliver 70-80 airplanes this year. During the quarter, Commercial Airplanes booked 460 net orders, including 220 for Air India and 39 for Riyadh Air, and secured a commitment from Ryanair for up to 300 737 MAX airplanes. Commercial Airplanes delivered 136 airplanes during the quarter and backlog included over 4,800 airplanes valued at $363B.

07:35 EDT Starbox Group launches StarBoxGPT AI content creation platform - Starbox Group announced the launch of "StarBoxGPT", an AI content creation platform that incorporates multimodal functions to provide AI service to Southeast Asia customers. StarBoxGPT is an AIGC comprehensive service platform independently developed by Starbox. StarBoxGPT includes the generation of text, image, speech, and video. StarBoxGPT's system is built based on technologies such as data integration, feature representation, translation, alignment, fusion techniques and co-learning. StarBoxGPT is designed to offer AI, augmented reality and automation solutions to optimize business process and IT operations for clients across various industries in Southeast Asia, to achieve cost savings, improve productivity, and reduce the time to value. Aiming to be a comprehensive AI solutions provider, Starbox is committed to providing end-to-end and customized services that will include strategy, designing, implementation and hands-on training to help clients deploy and scale AI solutions in an efficient and scalable way.

07:34 EDT Hess Corp. raises FY23 net production view to 385,000 boepd to 390,000 boepd - Full year net production is now forecast to be in the range of 385,000 boepd to 390,000 boepd, compared with previous guidance of 365,000 boepd to 375,000 boepd primarily due to strong operational performance and the expected startup of the Payara development early in the fourth quarter. CEO John Hess said: "We continue to successfully execute our strategy to deliver industry leading cash flow growth and financial returns to our shareholders while safely and responsibly producing oil and gas to help meet the world's growing energy needs."

07:33 EDT Incannex completes pre-IND meeting with FDA on IHL-675A in RA - Incannex Healthcare has completed a constructive pre-Investigational New Drug Application meeting with the U.S. Food and Drug Administration for its proprietary drug product IHL-675A for treatment of rheumatoid arthritis. IHL-675A is Incannex's proprietary combination product containing cannabidiol and hydroxychloroquine sulfate for treatment of inflammatory disorders including RA. Incannex submitted a pre-IND meeting package to the FDA in June 2023. The meeting package included a description of the unique formulation developed by Incannex, an overview of the proposed clinical development plan and specific questions Incannex submitted on the regulatory requirements for opening an Investigational New Drug application. Opening an IND is required to conduct trials in the United States and ensures that trials are designed so that they meet the data requirements necessary for FDA marketing approval. In the written correspondence, FDA provided valuable, multidisciplinary feedback on the proposed clinical development of IHL-675A. Importantly, the FDA confirmed that no further nonclinical studies are needed for the IND application. The FDA also provided specific guidance on what is required for Incannex to submit an NDA via the 505(b)(2) pathway, whereby some of the information required for marketing approval is derived from published studies on the components of IHL-675A and/or the Agency's findings on safety and/or effectiveness for relevant listed drugs. The FDA provided critical guidance on the proposed clinical development plan for IHL-675A. Incannex is incorporating this guidance into clinical trial designs and the overarching strategy for development of IHL-675A.

07:32 EDT Boeing reports Q2 operating cash flow $2.9B, free cash flow $2.6B - Reports cash and marketable securities of $13.8B.

07:31 EDT Boeing backs FY23 operating cash flow $4.5B-$6.5B; free cash flow $3B-$5B

07:23 EDT Zentek announces updated MRE for Albany Graphite Project - Zentek announced an updated Mineral Resource estimate for the Albany Graphite Project located north of Lake Superior and southwest of James Bay in Northeastern Ontario, which is owned by Zentek's wholly-owned subsidiary Albany Graphite Corp. AGC engaged SLR Consulting to update the Mineral Resource estimate that was previously disclosed in the Technical Report on The Preliminary Economic Assessment of the Albany Graphite Project, Northern Ontario, Canada prepared for the Company by Roscoe Postle Associates Inc. dated July 9, 2015. An updated Mineral Resource estimate is a requirement for AGC to list on a Canadian exchange. Mineral Resources of graphite are contained within two vertical pipes spaced approximately 250 m apart. The East Pipe is approximately 300 m long in the NW-SE direction by 50 m wide by 600 m deep. A halo of lower grade mineralization occurs around the East Pipe for a collective width of 150 m in the NE-SW direction. The West Pipe is approximately 300 m long in the NE-SW direction by 175 m wide by 500 m deep. Both pipes are cut by 10 m to 60 m thick barren sills located approximately 200 m to 300 m below topographic surface. SLR estimated Mineral Resources for the Albany Graphite Project using drill hole data available as of April 30, 2023. The Mineral Resource estimate is based on a potential combined Open Pit and Underground mining scenario using a price per tonne of purified graphite of US$8,000. The Mineral Resource estimate is based on a potential combined open pit and underground mining scenario, split by the barren sills. SLR estimates Indicated Mineral Resources to total 22.9 million tonnes ("Mt") at an average grade of 4.1% graphitic carbon, containing 933,000 tonnes of Cg. In addition, Inferred Mineral Resources are estimated to total 13.1 Mt at an average grade of 2.9% Cg, containing 375,000 tonnes of Cg. Inferred Mineral Resources include 3.4 Mt OP resources at an average grade of 2.5% Cg, containing 87,000 tonnes of Cg constrained by a Whittle pit shell, and 9.7 Mt of UG resources below the pit shell at an average grade of 3.0% Cg, containing 288,000 tonnes of Cg. In order to demonstrate Reasonable Prospects of Eventual Economic Extraction, OP Mineral Resources were reported within an optimized Whittle pit shell at a cut-off grade of 1.22% Cg and UG Mineral Resources were reported within underground resource reporting shapes, satisfying the minimum mining size and continuity criteria, and using a cut-off grade of 1.76% Cg.

07:20 EDT Verizon announces customers can qualify for NFL Sunday Tickets - Starting July 27, new Verizon (VZ) mobile and home internet customers can qualify for NFL Sunday Ticket exclusively from YouTube (GOOG;GOOGL) and YouTube TV - the League's subscription package that includes out-of-market Sunday afternoon regular-season NFL games broadcast on FOX (FOX) and CBS (PARA). Verizon customers who purchase or pre-order a select Smartphone and sign up for a new mobile line, or who sign up for select Verizon Home Internet plans, can also take advantage of NFL Sunday Ticket from YouTube TV. Hans Vestberg, chairman and CEO of Verizon: "By deepening our technology-first partnership with the NFL and now partnering with YouTube on NFL Sunday Ticket, we're able to offer customers the ultimate fan experience wherever they are on the most reliable 5G network in America. This partnership adds to our growing roster of the best content providers in the industry as we continue to deliver the best in choice and exclusive value to our customers."

07:17 EDT SpringBig highlights performance of its subscription loyalty service - springbig shared data highlighting the performance of its Subscription Loyalty Service. Released in June, the Subscription Loyalty Service offers retailers the ability to create and manage their paid-subscription programs. "Oasis Cannabis is one of several dispensaries to experience success after implementing the Subscription Loyalty Service," the company said. Since July 1st, the Las Vegas-based retailer has welcomed 117 new subscribers and recorded a 42.1% increase for visits per subscriber. Additional data shows subscribers visited Oasis Cannabis an additional time each month and their total spend increased 30% on average on the first visit, and 27% across all visits. Overall, Oasis Cannabis has recorded 339 subscriber visits and earned more than $22,000 in subscriber revenue since utilizing the Subscription Loyalty Service.

07:14 EDT Perpetua Resources subsidiary definitzes $24.8M agreement under DPA - Perpetua Resources announced that its wholly owned subsidiary, Perpetua Resources Idaho, definitized its previously announced Technology Investment Agreement of up to $24.8M under Title III of the Defense Production Act, or DPA. The funding objective of the TIA, issued by the Air Force Research Laboratory, is to complete environmental and engineering studies necessary to obtain a Final Environmental Impact Statement, a Final Record of Decision, and other ancillary permits to sustain the domestic production of antimony trisulfide capability for defense energetic materials. Antimony trisulfide is essential to national defense as a key component for munitions yet there is no U.S. mined supply. Under the funding agreement, Perpetua may request reimbursement for certain costs incurred over 24 months related to environmental baseline data monitoring, environmental and technical studies and other activities related to advancing Perpetua's construction readiness and permitting process for the Stibnite Gold Project. The DPA funding does not interrupt the ongoing National Environmental Policy Act review process.

07:12 EDT KKR and H.I.G Capital to acquire RBmedia, terms undisclosed - KKR and H.I.G. Capital announced that an affiliate of H.I.G. will acquire RBmedia and support its next phase of growth and development. RBmedia is an audiobook publisher with a digital distribution network that reaches millions of listeners around the globe. Upon closing of the transaction, all RBmedia employees will receive a cash payout based on their tenure with the company. Long-term employees will earn up to two times their annual salary. The transaction, which is subject to customary regulatory approvals, is expected to close by Q4.

07:11 EDT AC Immune appoints Mendonca as new Chief Medical Officer - AC Immune announced the appointment of Nuno Mendonca, MD. He will join the Company on October 1st, as Chief Medical Officer and be appointed to the Executive Committee. Johannes Streffer, MD, currently Chief Medical Officer, will leave at the end of September to pursue a new role. Prior to joining AC Immune SA Dr Mendonca was the Senior Vice-President, Chief Medical Officer of Bial.

07:09 EDT Tilray sees 2024 adjusted EBITDA $68M-$78M - For its fiscal year ended May 31, 2024, the Company expects to achieve adjusted EBITDA targets of $68 million to $78 million, representing growth of 11% to 27% as compared to fiscal year 2023. In addition, the Company expects to generate positive adjusted free cash flow.

07:02 EDT Stepan Company to reduce inventory levels by additional $40M - "Looking forward, we continue to believe second half of the year volume and margins will incrementally improve versus the first half of 2023, driven by the continued gradual recovery in Rigid Polyol demand, growth in Surfactant volumes associated with new contracted business and sequentially lower raw material costs," said Scott Behrens, president and CEO. "Further cost control and cash management initiatives are underway given the current business performance and include a voluntary early retirement program for eligible employees at our corporate headquarters and a plan to reduce inventory levels by an additional $40 million during the remainder of the year. Additionally, capital spending in the second half of the year is projected to be in the range of $80 to $90 million, down from the record $160 million spent in the first half of the year, due to the expected completion of our low 1,4 dioxane investments in the coming weeks and lower second half capital spending required to complete our Pasadena alkoxylation investment which is expected to be operational mid-year 2024. While we acknowledge the current environment has been challenging, we remain confident in our long-term strategic growth and innovation initiatives."

06:58 EDT Coca-Cola reports Q2 global unit case volume even

06:42 EDT New Found Gold begins Phase II 10,000m drill program at Queensway South - New Found Gold announced commencement of a Phase II, 10,000m drill program at Queensway South, or QWS, designed to follow up on results from its inaugural 2022 program that tested early-stage exploration targets along an 18.5km long stretch of the Appleton Fault Zone, or AFZ, approximately 50km south of the Keats Zone. The inaugural 2022 drill program intersected significant gold mineralization in 27 of 33 drill holes and visible gold in 10 drill holes across four target areas. QWS is a contiguous portion of New Found's 100%-owned Queensway project and covers roughly 65km of strike extension on the regional Appleton and JBP Fault Zones across 1320km2 of the Queensway project's total area of 1,662km2. QWS is easily accessed via the Trans-Canada Highway and a network of forestry roads. Drill Program Highlights include: The Company is planning follow up drilling at Pauls Pond, an area covering a high concentration of gold anomalies on both sides of the AFZ. Seventeen drillholes were completed in 2022 leading to three new discoveries: "Astronaut", "Nova" and "Nebula". Astronaut and Nova are parallel structures located west of the AFZ that have been traced over 1,600m and 250m of strike length, respectively. At Astronaut and Nova, eight out of nine holes drilled contained visible gold, including highlight interval of 19.0 g/t Au over 3.15m in NFGC-QS-22-20. Nebula, the third discovery in the Pauls Pond area, is located on the east side of the AFZ and drill testing of a prominent Au-in-soil anomaly with two holes identified significant mineralization that is associated with a near-surface shear zone that returned an initial highlight result of 3.70 g/t Au over 4.30m in NFGC-QS-22-25. Drilling is also planned at the Devils Pond Trend, located on the east side of the AFZ where 2022 drill testing of two trenched Au-in soil and till anomalies led to two new discoveries, "Devils Pond" and "Devils Pond South". These zones are located 12km apart and all drillholes at both targets intersected broad domains of highly anomalous gold including highlight intervals of 0.47 g/t Au over 8.00m and 0.37 g/t Au over 28.00m in NFGC-QS-22-15 at Devils Pond and 1.01 g/t Au over 8.80m in NFGC-QS-22-30 at Devils Pond South. Several new high-priority drill targets resulting from ongoing prospecting, mapping, soil, till and grab sampling, and trenching have been developed that will be drill tested during the 2023 Phase II program.

06:35 EDT Crescent Point Energy sees FY23 capital expenditures C$1.19B-C$1.29B

06:28 EDT Crescent Point Energy announces 3.5c per share special cash dividend - Crescent Point Energy announced its board of directors has declared a special cash dividend and a quarterly cash base dividend in alignment with the company's return of capital framework. The special cash dividend of CDN $0.035 per share is based on Crescent Point's second quarter 2023 financial results and will be paid on August 15 for shareholders of record on August 8. The quarterly cash base dividend of CDN 10c per share will be paid on October 2 for shareholders of record on September 15. These dividends are designated as "eligible dividends" for Canadian income tax purposes. For U.S. income tax purposes, Crescent Point's dividends are considered "qualified dividends."

06:22 EDT Taylor Morrison sees FY23 home closings 11,000 - Sees FY23 average closing price $625,000. Sees FY23 ending active community count 320-325. Sees FY23 effective tax rate 25%.

06:17 EDT Lloyds Banking sees FY23 banking NIM above 310 basis points - The bank said, "Based on our purpose-driven strategy, robust financial performance and the Group's revised macroeconomic forecasts, we are enhancing our 2023 guidance and now expect: Banking net interest margin to be greater than 310 basis points; Operating costs to be c.GBP 9.1B; Asset quality ratio to be c.30 basis points; Return on tangible equity to be greater than 14 per cent; Capital generation to be c.175 basis points."

06:07 EDT Deutsche Bank affirms 2023 capital distribution goals - Deutsche Bank has received supervisory approvals for further share repurchases of up to EUR 450 million by year-end 2023. The bank plans to commence these repurchases in August. Anticipated 2023 share repurchases are 50% higher than in 2022, consistent with the 50% dividend growth already delivered in respect of the financial year 2022. The bank aims for total share repurchases and dividends of over EUR 1 billion in 2023, bringing total distributions to shareholders over 2022 and 2023 to approximately EUR 1.75 billion. Deutsche Bank reaffirmed its capital objectives of EUR 8 billion in capital distributions for the financial years 2021-2025; 50% dividend growth per year in respect of the financial years 2022-2024, and a 50% payout ratio from 2025.

05:43 EDT Apple, Amazon face U.K. legal action over price collusion claim - Alleged ongoing collusion between Amazon (AMZN) and Apple (AAPL) is revealed in a new collective action filed in the UK Competition Appeal Tribunal, which demands compensation for millions of consumers. "The collective action seeks at least GBP 500M for UK consumers impacted by a secret deal between the global corporations, which saw Amazon restricting sales of popular Apple products by independent merchants on its popular marketplace. In return, Apple offered Jeff Bezos's firm preferential wholesale prices on all Apple and Beats products, which it could sell directly to customers via its own retail business. he claim alleges that, by January 2019, almost all independent merchants of Apple and Beats products disappeared from the Amazon marketplace as a result of Apple and Amazon's collusion. This led to a decrease in the discounts provided to customers by the limited number of independent merchants remaining, and a significant increase in the sales of Apple and Beats products at undiscounted prices. This deal was struck in October 2018, and its continuing effect is to keep the prices of Apple and Beats products, including iPhones, iPads and MacBooks, artificially high for the benefit of Apple and at the expense of UK consumers. Amazon also benefited, as the deal enabled it to sell more Apple and Beats products at higher prices directly to consumers." Reference Link